Christopher B. Primiano

2014

In 2014, Christopher B. Primiano earned a total compensation of $2.2M as Senior Vice President, Corporate Development, General Counsel and Secretary at Karyopharm Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$60,500
Option Awards$1,871,595
Salary$213,750
Other$7,982
Total$2,153,827

Primiano received $1.9M in option awards, accounting for 87% of the total pay in 2014.

Primiano also received $60.5K in non-equity incentive plan, $213.8K in salary and $8K in other compensation.

Rankings

In 2014, Christopher B. Primiano's compensation ranked 4,221st out of 13,032 executives tracked by ExecPay. In other words, Primiano earned more than 67.6% of executives.

ClassificationRankingPercentile
All
4,221
out of 13,032
68th
Division
Manufacturing
1,489
out of 4,966
70th
Major group
Chemicals And Allied Products
487
out of 1,686
71st
Industry group
Drugs
377
out of 1,365
72nd
Industry
Pharmaceutical Preparations
301
out of 1,043
71st
Source: SEC filing on April 29, 2016.

Primiano's colleagues

We found four more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2014.

2014

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

2014

Ran Frenkel

Karyopharm Therapeutics

Executive Vice President, Worldwide Development Operations

2014

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2014

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

News

In-depth

You may also like